CD4 and neoplasm: found that ICI treatment in BCC and SCC increases the frequency of CXCR5+ Tfh cells, along with enhanced clonality within this population.[100] These findings suggest that specific CD4+ T cells, which exhibit features of both Th1 and Tfh cells, play a pivotal role in anti‐tumor immunity and contribute to ICI responses (Figure 2).